Kelly Sherrill
Adult Health · Dothan, ALNPI 1063113033
Payments from drug & device makers
Across 70 payments — averaging $23.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$430
- Lilly USA, LLC$189
- Novo Nordisk$173
- AstraZeneca$117
- Idorsia Pharmaceuticals US Inc$116
- Bayer$102
- plus $550 from 15 others
What the payments were for
- Food & beverage$1,676100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 15 | $430 |
| Lilly USA, LLC | 9 | $189 |
| Novo Nordisk | 6 | $173 |
| AstraZeneca | 7 | $117 |
| Idorsia Pharmaceuticals US Inc | 1 | $116 |
| Bayer | 5 | $102 |
| Pfizer | 5 | $95 |
| Medtronic | 2 | $65 |
| AbbVie | 3 | $63 |
| Radius Health, Inc. | 3 | $51 |
| Dexcom, Inc. | 2 | $44 |
| Amgen | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Corcept Therapeutics | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $16 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,676 in reported general payments places this provider in the 70th percentile of 308 adult health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 47 | $51,631 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $38,782 |
| FarxigaDapagliflozin Propanediol | 37 | $36,787 |
| MounjaroTirzepatide | 26 | $31,674 |
| EliquisApixaban | 21 | $29,964 |
| JardianceEmpagliflozin | 26 | $26,478 |
| TrulicityDulaglutide | 22 | $23,374 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $13,189 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,028 |
| Rosuvastatin Calcium | 142 | $1,816 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $1,734 |
| Fluticasone Propionate | 131 | $1,653 |
| Pantoprazole Sodium | 125 | $1,540 |
| Losartan Potassium | 174 | $1,517 |
| Amlodipine Besylate | 173 | $1,089 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30 | $189 | $56,09260 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $430 | $51,97081 claims |
| Novo NordiskOzempic | $173 | $51,63147 claims |
| AstraZenecaFarxiga | $117 | $36,78737 claims |
| PfizerEliquis | $95 | $29,96421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 308 adult health providers in Alabama.
Other adult health in Dothan
- Cara HinckleyDothan$8K
- Emily PettisDothan$6K
- Susan BroylesDothan$3K
- Wendy CantrellMountain Brk$276K
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Olivia ViseHoover$15K
- Lindsay SmithPelham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.